Africa: Advantage Health Africa Appoints MD for Advantage Pharmaceuticals Limited

Advantage Health Africa (AHA) has appointed Mr. Michael Heavens as the Managing Director/CEO, Advantage Pharmaceuticals Limited (APL).

APL is the health technology innovator’s latest venture to improve healthcare in the country.

In this role, AHA says Heavens wil pilot the company’s goal of providing access to genuine and affordable drugs through manufacture and distribution.

With the advent of the pandemic, the organisation says it understands the gap in the supply chain for medications in Nigeria.

Hence, it has decided to actively pursue bridging this through linking the people directly with the medicines and medical devices faster than ever before, with assured quality.

Coming with a strong pharma industry know-how, Heavens acknowledged that pharmaceutical sector is about to open up.

He further said that the sector needs deep investments, committed players and dedicated teams to make things work.

“I see my role leading APL as a hallmark in my career that will certainly make the right kind of impact we need in healthcare,” he added.

According to APL, making major contributions to the development of this sector is at the core of APL, by ensuring the provision of genuine medication across Nigeria.

With this drive, APL has a focus on local production as much as possible. “Heavens will serve as the pioneering lead of the venture.”

The new MD is said to have expertise in pharmaceutical sales and marketing accumulated in several leading indigenous pharmaceutical companies in almost two decades.